Key facts: Aehr record Q1; $150M outlook; FOX-XP eval; 12+ prospects

What happened

Aehr Test Systems reported record fiscal Q1 2027 revenue of $33 million, up 200% year over year, with $46.7 million in bookings. It raised its fiscal-year revenue outlook to $150 million and said cash fell to $105.1 million from $116.5 million.

Confirmed

Global impact / market context

The $150 million outlook implies Aehr expects much more revenue than the record quarter alone would suggest, so future sales depend on converting bookings and evaluations into orders. If those tests succeed, revenue and cash available should rise; if they stall, its cash balance could keep shrinking.

Analyst inference

Aehr sells test equipment used to check chips before shipment, tying its results to chipmakers adding capacity. A large supplier evaluating a FOX-XP test cell in Taiwan, plus more than a dozen prospects, signals possible demand beyond its lead customer, though evaluation units are not guaranteed orders.

Analyst inference

What to watch

1. Watch whether the large chip supplier that plans to evaluate Aehr's FOX-XP burn-in test cell in Taiwan, with installation set for early 2027, places a full order after the test. Confirmed
2. Aehr's expanded pipeline of more than a dozen potential customers across AI processors, silicon photonics, silicon carbide and gallium nitride could be watched to see which convert into firm orders. Proposed
3. Watch cash of $105.1 million, down from $116.5 million, since continued spending while waiting for orders could reduce the cash available to fund operations. Analyst inference

Evidence

• Original source link unavailable